This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Leiden, the Netherlands, April 8, 2024: Pharming.
Pharming Group announces the 2024 Annual General Meeting of globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. announces that the Company’s 2024 Annual General Meeting of Shareholders will be held on Tuesday, May 21, 2024 at 14:30 CEST. The.
Leiden, The Netherlands, April 4, 2024: Pharming Group N.V. announces the filing of its Annual Report for the year ended December 31, 2023 . The Annual Report is available under Investors/Financial.